Evidence map›Paper›PMID 39713583›Full record

ArticleInternational journal of cardiology. Congenital heart disease2023

Prevalence of traditional and non-traditional cardiovascular risk factors in adults with congenital heart disease.

Jacqueline Levene, Claire Cambron, Lidija McGrath, Ibett Colina Garcia, Craig Broberg, Katrina Ramsey, Abigail Khan

Abstract read
In one paragraph

Article in International journal of cardiology. Congenital heart disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Biological Age in Congenital Heart Disease-Exploring the Ticking Clock.Journal of cardiovascular development and disease · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jacqueline LeveneDepartment of Medicine, Oregon Health & Science University, Portland, OR, USA.
Claire CambronDepartment of Medicine, Oregon Health & Science University, Portland, OR, USA.
Lidija McGrathAdult Congenital Heart Disease Program, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Ibett Colina GarciaAdult Congenital Heart Disease Program, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Craig BrobergAdult Congenital Heart Disease Program, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Katrina RamseyDivision of Biostatistics and Epidemiology, Oregon Health & Science University, Portland, OR, USA.
Abigail KhanAdult Congenital Heart Disease Program, Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adults with congenital heart disease (CHD) may be at increased risk of acquired cardiovascular disease (CVD). Understanding the prevalence of CV risk factors (CVRF) in this population is an important step in developing strategies to mitigate long-term risk. Methods: The Oregon All Payer All Claims database for the years 2010-2017 was queried for adults with CHD International Classification of Diseases (ICD) codes. The prevalence of CVRF was measured, and we then evaluated the association with patient characteristics. Results: There were 13,896 individuals with CHD. 72.8% (99% CI: 71.8-73.7) had at least one RF and 52.3% (99% CI: 51.2-53.4) had ≥2 RF. The prevalence of ≥1 RF increased with age (18-24: 39.6% (99% CI: 37.0-42.1) vs. 93.6% (99% CI: 92.6-94.6) in those 55-65). Hypertension (aOR 1.49 (99% CI: 1.36-1.63)), diabetes (aOR 1.24 (99% CI: 1.13-1.36)), sleep apnea (aOR 1.40 (99% CI 1.26-1.55)) and kidney disease (aOR 1.33 (99% CI:1.14-1.54)) were more prevalent in moderate-complex as opposed to simple CHD. When compared with a matched non-CHD population, there was higher prevalence of CVRF in ACHD (≥1 RF: 76.1 vs. 64.1%, OR 1.79 (99% CI: 1.69-1.89); ≥2 RF: 52.6 vs. 36.5%, OR 1.92 (99% CI: 1.83-2.03). Conclusions: To our knowledge, this is the first comprehensive attempt to measure both traditional and non-traditional CVRF in US adults with CHD. We show that CVRF are common even in young adults. Given the additive effect of acquired CVD on CHD, addressing RF should be an important priority for in ACHD.

Indexed as

Cardiac preventionCongenital heart diseaseRisk assessment

Identifiers

PMID39713583
PMCPMC11658359

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.